[1] |
ESTEVES F, MEDRANO F J, DE ARMAS Y,et al. Pneumocystis and pneumocystosis:first meeting of experts from Latin-American and Portuguese-speaking countries - a mini-review[J]. Expert Rev Anti Infect Ther, 2014, 12(5):545-548. DOI: 10.1586/14787210.2014.894883.
|
[2] |
ESTEVES F, CALÉ S S, BADURA R,et al. Diagnosis of pneumocystis pneumonia:evaluation of four serologic biomarkers[J]. Clin Microbiol Infect, 2015, 21(4):379.e1-379.10. DOI: 10.1016/j.cmi.2014.11.025.
|
[3] |
|
[4] |
SONG Y G, REN Y, WANG X W,et al. Recent advances in the diagnosis of pneumocystis pneumonia[J]. Med Mycol J, 2016, 57(4):E111-116. DOI: 10.3314/mmj.16-00019.
|
[5] |
WHITE P L, POSSO R B, GORTON R L,et al. An evaluation of the performance of the Dynamiker® Fungus(1-3)-β-D-Glucan Assay to assist in the diagnosis of pneumocystis pneumonia[J]. Med Mycol, 2017, 56(6):778-781. DOI: 10.1093/mmy/myx097.
|
[6] |
TASAKA S. Serum(1→3)β-d-glucan assay for discrimination between pneumocystis jirovecii pneumonia and colonization[J]. J Infect Chemother, 2014, 20(11):678-681. DOI: 10.1016/j.jiac.2014.07.001.
|
[7] |
MIAO Q, MA Y Y, WANG Q Q,et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice[J]. Clin Infect Dis, 2018, 67(suppl_2):S231-240. DOI: 10.1093/cid/ciy693.
|
[8] |
WU X D, LI Y Y, ZHANG M,et al. Etiology of severe community-acquired pneumonia in adults based on metagenomic next-generation sequencing:a prospective multicenter study[J]. Infect Dis Ther, 2020, 9(4):1003-1015. DOI: 10.1007/s40121-020-00353-y.
|
[9] |
|
[10] |
DEURENBERG R H. Application of next generation sequencing in clinical microbiology and infection prevention[J]. J Biotechnol, 2017, 243:16-24. DOI: 10.1016/j.jbiotec.2016.12.022.
|
[11] |
|
[12] |
ROSSEN J W A, FRIEDRICH A W, MORAN-GILAD J,et al. Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology[J]. Clin Microbiol Infect, 2018, 24(4):355-360. DOI: 10.1016/j.cmi.2017.11.001.
|
[13] |
|
[14] |
MA L, CISSÉ O H, KOVACS J A. A molecular window into the biology and epidemiology of pneumocystis spp[J]. Clin Microbiol Rev, 2018, 31(3):e00009-00018. DOI: 10.1128/CMR.00009-18.
|
[15] |
MORRIS A, NORRIS K A. Colonization by pneumocystis jirovecii and its role in disease[J]. Clin Microbiol Rev, 2012, 25(2):297-317. DOI: 10.1128/CMR.00013-12.
|
[16] |
BABIC-ERCEG A, VILIBIC-CAVLEK T, ERCEG M,et al. Prevalence of pneumocystis jirovecii pneumonia(2010-2013):the first Croatian report[J]. Acta Microbiol Immunol Hung, 2014, 61(2):181-188. DOI: 10.1556/AMicr.61.2014.2.8.
|
[17] |
LOWE D M, RANGAKA M X, GORDON F,et al. Pneumocystis jirovecii pneumonia in tropical and low and middle income countries:a systematic review and meta-regression[J]. PLoS One, 2013, 8(8):e69969. DOI: 10.1371/journal.pone.0069969.
|
[18] |
SWAIN S D, SIEMSEN D W, PULLEN R R,et al. CD 4+ T cells and IFN-γ are required for the development of pneumocystis-associated pulmonary hypertension[J]. Am J Pathol, 2014, 184(2):483-493. DOI: 10.1016/j.ajpath.2013.10.027.
|
[19] |
RIEBOLD D, ENOH D O, KINGE T N,et al. Pneumocystis jirovecii colonisation in HIV-positive and HIV-negative subjects in Cameroon[J]. Trop Med Int Health, 2014, 19(6):643-655. DOI: 10.1111/tmi.12299.
|
[20] |
LIU L, YUAN M J, SHI Y,et al. Clinical performance of BAL metagenomic next-generation sequence and serum(1,3)-β-D-glucan for differential diagnosis of pneumocystis jirovecii pneumonia and pneumocystis jirovecii colonisation[J]. Front Cell Infect Microbiol, 2021, 11:784236. DOI: 10.3389/fcimb.2021.784236.
|
[21] |
DAMIANI C, LE GAL S, DA COSTA C,et al. Combined quantification of pulmonary pneumocystis jirovecii DNA and serum(1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and pneumocystis colonization[J]. J Clin Microbiol, 2013, 51(10):3380-3388. DOI: 10.1128/JCM.01554-13.
|
[22] |
JIANG J, BAI L, YANG W,et al. Metagenomic next-generation sequencing for the diagnosis of pneumocystis jirovecii pneumonia in non-HIV-infected patients:a retrospective study[J]. Infect Dis Ther, 2021, 10(3):1733-1745. DOI: 10.1007/s40121-021-00482-y.
|
[23] |
HELD J, KOCH M S, REISCHL U,et al. Serum(1→3)-β-D-glucan measurement as an early indicator of pneumocystis jirovecii pneumonia and evaluation of its prognostic value[J]. Clin Microbiol Infect, 2011, 17(4):595-602. DOI: 10.1111/j.1469-0691.2010.03318.x.
|